Human trials for Zika vaccine to begin this week

peter-abbink-lab-researcher-at-center-for-virology-and-vaccine-reseaerch-harvard-university
Peter Abbink, lab researcher at the Center for Virology and Vaccine Research, Harvard University (Courtesy of Barouch Lab/Harvard Medical School/Beth Israel Deaconess)

(BOSTON) OCT 29 – THERE’S PROGRESS IN THE HUNT FOR PROTECTION AGAINST THE ZIKA VIRUS.
FOX NEWS RADIO’S BILL MARCUS HAS MORE.

ABBINK IS NOW AT AN IMMUNOLOGY CONFERENCE IN BRAZIL WHERE HE’S PRESENTING THE RESULTS OF HIS LAB’S WORK ON MICE AND MONKEYS. THE TEAM FROM HARVARD MEDICAL SCHOOL, WALTER REED ARMY INSTITUTE OF RESEARCH,  AND BETH ISRAEL DEACONESS MEDICAL CENTER PUBLISHED THEIR WORK IN SEPTEMBER IN THE JOURNAL NATURE.  THE VACCINE WAS EFFECTIVE ON STRAINS OF THE VIRUS FROM BOTH PUERTO RICO AND BRAZIL.
***
LAB RESEARCHER PETER ABBINK SAYS HUMAN TRIALS WILL BEGIN THIS WEEK.